{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:41:22Z","timestamp":1783964482114,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["2023YFS0047"],"award-info":[{"award-number":["2023YFS0047"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903722"],"award-info":[{"award-number":["81903722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40262-025-01510-7","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:41:48Z","timestamp":1749030108000},"page":"1179-1190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Obesity on Pharmacokinetics of Lidocaine and its Active Metabolites in Chinese Patients Undergoing Laparoscopic Bariatric Surgery: A Prospective Clinical Study"],"prefix":"10.1007","volume":"64","clinical-trial-number":[{"clinical-trial-number":"chictr2200064980","registry":"10.18810\/chictr"}],"author":[{"given":"Mengyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faping","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-4219","authenticated-orcid":false,"given":"Zhenlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"1510_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.metabol.2018.10.011","volume":"92","author":"C Koliaki","year":"2019","unstructured":"Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98\u2013107. https:\/\/doi.org\/10.1016\/j.metabol.2018.10.011.","journal-title":"Metabolism"},{"issue":"11","key":"1510_CR2","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.115.306825","volume":"118","author":"SN Bhupathiraju","year":"2016","unstructured":"Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723\u201335. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306825.","journal-title":"Circ Res"},{"key":"1510_CR3","doi-asserted-by":"publisher","unstructured":"Zorena K, Jachimowicz-Duda O, \u015al\u0119zak D, et al. Adipokines and obesity. potential link to metabolic disorders and chronic complications. Int J Mol Sci. 2020;21(10):3570. https:\/\/doi.org\/10.3390\/ijms21103570.","DOI":"10.3390\/ijms21103570"},{"issue":"11","key":"1510_CR4","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1161\/CIRCRESAHA.116.307591","volume":"118","author":"BM Wolfe","year":"2016","unstructured":"Wolfe BM, Kvach E, Eckel RH. Treatment of obesity: weight loss and bariatric surgery. Circ Res. 2016;118(11):1844\u201355. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.307591.","journal-title":"Circ Res"},{"issue":"2","key":"1510_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/13697137.2017.1262638","volume":"20","author":"E Panteliou","year":"2017","unstructured":"Panteliou E, Miras AD. What is the role of bariatric surgery in the management of obesity? Climacteric. 2017;20(2):97\u2013102. https:\/\/doi.org\/10.1080\/13697137.2017.1262638.","journal-title":"Climacteric"},{"issue":"41","key":"1510_CR6","doi-asserted-by":"publisher","first-page":"15135","DOI":"10.3748\/wjg.v20.i41.15135","volume":"20","author":"M Sundbom","year":"2014","unstructured":"Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol. 2014;20(41):15135\u201343.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"1510_CR7","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.3748\/wjg.v20.i41.15135","volume":"29","author":"S Pouwels","year":"2019","unstructured":"Pouwels S, Buise MP, Twardowski P, et al. Obesity surgery and anesthesiology risks: a review of key concepts and related physiology. Obes Surg. 2019;29(8):2670\u20137. https:\/\/doi.org\/10.3748\/wjg.v20.i41.15135.","journal-title":"Obes Surg"},{"issue":"3","key":"1510_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/17425255.2018.1440287","volume":"14","author":"C Smit","year":"2018","unstructured":"Smit C, De Hoogd S, Br\u00fcggemann RJM, et al. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters. Expert Opin Drug Metab Toxicol. 2018;14(3):275\u201385. https:\/\/doi.org\/10.1080\/17425255.2018.1440287.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"10","key":"1510_CR9","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1124\/dmd.116.071605","volume":"44","author":"D Dong","year":"2016","unstructured":"Dong D, Peng X, Liu J, et al. Morbid obesity alters both pharmacokinetics and pharmacodynamics of propofol: dosing recommendation for anesthesia induction. Drug Metab Dispos. 2016;44(10):1579\u201383. https:\/\/doi.org\/10.1124\/dmd.116.071605.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"1510_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00000542-198204000-00007","volume":"56","author":"D Jung","year":"1982","unstructured":"Jung D, Mayersohn M, Perrier D, et al. Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology. 1982;56(4):269\u201374. https:\/\/doi.org\/10.1097\/00000542-198204000-00007.","journal-title":"Anesthesiology"},{"issue":"1","key":"1510_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.soard.2021.08.014","volume":"18","author":"KC Hung","year":"2022","unstructured":"Hung KC, Chang YJ, Chen IW, et al. Efficacy of intraoperative intravenous lidocaine for postoperative analgesia following bariatric surgery: a meta-analysis of randomized controlled studies. Surg Obes Relat Dis. 2022;18(1):135\u201347. https:\/\/doi.org\/10.1016\/j.soard.2021.08.014.","journal-title":"Surg Obes Relat Dis."},{"issue":"4","key":"1510_CR12","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s11695-019-04340-2","volume":"30","author":"RK Sakata","year":"2020","unstructured":"Sakata RK, de Lima RC, Valadao JA, et al. Randomized, double-blind study of the effect of intraoperative intravenous lidocaine on the opioid consumption and criteria for hospital discharge after bariatric surgery. Obes Surg. 2020;30(4):1189\u201393. https:\/\/doi.org\/10.1007\/s11695-019-04340-2.","journal-title":"Obes Surg"},{"key":"1510_CR13","doi-asserted-by":"publisher","first-page":"Cd009642","DOI":"10.1002\/14651858.CD009642.pub2","volume":"7","author":"P Kranke","year":"2015","unstructured":"Kranke P, Jokinen J, Pace NL, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015;7:Cd009642. https:\/\/doi.org\/10.1002\/14651858.CD009642.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1510_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2147\/DDDT.S356880","volume":"16","author":"J Sun","year":"2022","unstructured":"Sun J, Wang S, Wang J, et al. Effect of Intravenous Infusion of Lidocaine Compared with Ultrasound-Guided Transverse Abdominal Plane Block on the Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery. Drug Des Devel Ther. 2022;16:739\u201348. https:\/\/doi.org\/10.2147\/DDDT.S356880.","journal-title":"Drug Des Devel Ther."},{"issue":"5 Suppl","key":"1510_CR15","doi-asserted-by":"publisher","first-page":"21S","DOI":"10.1177\/0148607111413773","volume":"35","author":"D Gallagher","year":"2011","unstructured":"Gallagher D, DeLegge M. Body composition (sarcopenia) in obese patients: implications for care in the intensive care unit. JPEN J Parenter Enteral Nutr. 2011;35(5 Suppl):21S-S28. https:\/\/doi.org\/10.1177\/0148607111413773.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"8","key":"1510_CR16","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/0002-9149(84)90659-3","volume":"53","author":"DR Abernethy","year":"1984","unstructured":"Abernethy DR, Greenblatt DJ. Lidocaine disposition in obesity. Am J Cardiol. 1984;53(8):1183\u20136. https:\/\/doi.org\/10.1016\/0002-9149(84)90659-3.","journal-title":"Am J Cardiol"},{"key":"1510_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115281","volume":"166","author":"J Gouju","year":"2023","unstructured":"Gouju J, Legeay S. Pharmacokinetics of obese adults: Not only an increase in weight. Biomed Pharmacother. 2023;166: 115281. https:\/\/doi.org\/10.1016\/j.biopha.2023.115281.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"1510_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bjae.2018.09.001","volume":"18","author":"CP Hebbes","year":"2018","unstructured":"Hebbes CP, Thompson JP. Pharmacokinetics of anaesthetic drugs at extremes of body weight. BJA Educ. 2018;18(12):364\u201370. https:\/\/doi.org\/10.1016\/j.bjae.2018.09.001.","journal-title":"BJA Educ."},{"issue":"14","key":"1510_CR19","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.2147\/DDDT.S266062","volume":"27","author":"X Li","year":"2020","unstructured":"Li X, Lv X, Jiang Z, Nie X, Wang X, Li T, Zhang L, Liu S. Application of intravenous lidocaine in obese patients undergoing painless colonoscopy: a prospective, randomized, double-blind, controlled study. Drug Des Devel Ther. 2020;27(14):3509\u201318. https:\/\/doi.org\/10.2147\/DDDT.S266062.","journal-title":"Drug Des Devel Ther."},{"issue":"2","key":"1510_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11695-013-1077-x","volume":"24","author":"GS De Oliveira","year":"2014","unstructured":"De Oliveira GS, Duncan K, Fitzgerald P, et al. Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery: a randomized double-blinded placebo-controlled trial. Obes Surg. 2014;24(2):212\u20138. https:\/\/doi.org\/10.1007\/s11695-013-1077-x.","journal-title":"Obes Surg"},{"issue":"4","key":"1510_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.asj.2004.05.001","volume":"24","author":"TJ Bill","year":"2004","unstructured":"Bill TJ, Clayman MA, Morgan RF, et al. Lidocaine metabolism pathophysiology, drug interactions, and surgical implications. Aesthet Surg J. 2004;24(4):307\u201311. https:\/\/doi.org\/10.1016\/j.asj.2004.05.001.","journal-title":"Aesthet Surg J"},{"issue":"6","key":"1510_CR22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/cpt1978246654","volume":"24","author":"PK Narang","year":"1978","unstructured":"Narang PK, Crouthamel WG, Carliner NH, et al. Lidocaine and its active metabolites. Clin Pharmacol Ther. 1978;24(6):654\u201362. https:\/\/doi.org\/10.1002\/cpt1978246654.","journal-title":"Clin Pharmacol Ther"},{"key":"1510_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123362","volume":"1207","author":"Y Jin","year":"2022","unstructured":"Jin Y, He C, Di X, et al. Simultaneous determination of lidocaine and its active metabolites in plasma by UPLC-MS\/MS and application to a clinical pharmacokinetic study in liver cancer patients with laparoscopic hepatectomy. J Chromatogr B Analyt Technol Biomed Life Sci. 2022;1207: 123362. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123362.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"1510_CR24","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.21037\/apm-20-1223","volume":"9","author":"G Xu","year":"2020","unstructured":"Xu G, Qiao N, Pan Y, Simayi A, Chen N. The appropriate dose of propofol for anesthesia induction in morbidly obese patients. Ann Palliat Med. 2020;9(4):1921\u20137. https:\/\/doi.org\/10.21037\/apm-20-1223.","journal-title":"Ann Palliat Med."},{"issue":"10","key":"1510_CR25","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1124\/dmd.116.071605","volume":"44","author":"D Dong","year":"2016","unstructured":"Dong D, Peng X, Liu J, Qian H, Li J, Wu B. Morbid obesity alters both pharmacokinetics and pharmacodynamics of propofol: dosing recommendation for anesthesia induction. Drug Metab Dispos. 2016;44(10):1579\u201383. https:\/\/doi.org\/10.1124\/dmd.116.071605.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"1510_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1213\/ane.0b013e3181b0826a","volume":"109","author":"CS Meyhoff","year":"2009","unstructured":"Meyhoff CS, Lund J, Jenstrup MT, Claudius C, S\u00f8rensen AM, Viby-Mogensen J, Rasmussen LS. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? Anesth Analg. 2009;109(3):787\u201392. https:\/\/doi.org\/10.1213\/ane.0b013e3181b0826a.","journal-title":"Anesth Analg"},{"key":"1510_CR27","unstructured":"The Food and Drug Administration (2018) Bioanalytical method validation guidance for industry. https:\/\/www.fda.gov\/media\/70858\/download. Accessed 3 May 2022"},{"key":"1510_CR28","unstructured":"European Medicines Agency (2015) Guideline on bioanalytical method validation. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf. Accessed 3 May 2022"},{"key":"1510_CR29","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","volume":"44","author":"S Janmahasatian","year":"2005","unstructured":"Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44:1051\u201365. https:\/\/doi.org\/10.2165\/00003088-200544100-00004.","journal-title":"Clin Pharmacokinet"},{"key":"1510_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11154-020-09566-5","volume":"21","author":"I Laurent","year":"2020","unstructured":"Laurent I, Ast\u00e8re M, Paul B, et al. The use of Broca index to assess cut-off points for overweight in adults: a short review. Rev Endocr Metab Disord. 2020;21:521\u20136. https:\/\/doi.org\/10.1007\/s11154-020-09566-5.","journal-title":"Rev Endocr Metab Disord"},{"key":"1510_CR31","unstructured":"HODGMAN T. Lidocaine. In: Cohen H. eds. Casebook in Clinical Pharmacokinetics and Drug Dosing. McGraw-Hill Education; 2015. https:\/\/accesspharmacy.mhmedical.com\/content.aspx?bookid=1514&sectionid=88804068 Accessed 2 Mar 2024."},{"issue":"2","key":"1510_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/bjaceaccp\/mkh042","volume":"4","author":"LE De Baerdemaeker","year":"2004","unstructured":"De Baerdemaeker LE, Mortier EP, Struys MM. Pharmacokinetics in obese patients. Continuing Education in Anaesthesia Critical Care & Pain. 2004;4(2):152\u20135. https:\/\/doi.org\/10.1093\/bjaceaccp\/mkh042.","journal-title":"Continuing Education in Anaesthesia Critical Care & Pain."},{"issue":"11","key":"1510_CR33","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/jcph.2093","volume":"62","author":"DJ Greenblatt","year":"2022","unstructured":"Greenblatt DJ, Bruno CD, Harmatz JS, et al. Drug disposition in subjects with obesity: the research work of Darrell R. Abernethy J Clin Pharmacol. 2022;62(11):1350\u201363. https:\/\/doi.org\/10.1002\/jcph.2093.","journal-title":"Abernethy. J Clin Pharmacol."},{"issue":"1","key":"1510_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clpt.2003.09.007","volume":"75","author":"R Orlando","year":"2004","unstructured":"Orlando R, Piccoli P, De Martin S, Padrini R, Floreani M, Palatini P. Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function. Clin Pharmacol Ther. 2004;75(1):80\u20138. https:\/\/doi.org\/10.1016\/j.clpt.2003.09.007.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"1510_CR35","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2165\/00003088-200847110-00005","volume":"47","author":"AN Edginton","year":"2008","unstructured":"Edginton AN, Willmann S. Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis. Clin Pharmacokinet. 2008;47(11):743\u201352. https:\/\/doi.org\/10.2165\/00003088-200847110-00005.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1510_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1365-2125.2003.01718.x","volume":"55","author":"R Orlando","year":"2003","unstructured":"Orlando R, Piccoli P, De Martin S, Padrini R, Palatini P. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function. Br J Clin Pharmacol. 2003;55(1):86\u201393. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01718.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1510_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1742-7843.2010.00657.x","volume":"108","author":"BX He","year":"2011","unstructured":"He BX, Shi L, Qiu J, Tao L, Li R, Yang L, et al. A functional polymorphism in the CYP3A4 gene is associated with increased risk of coronary heart disease in the Chinese Han population. Basic Clin Pharmacol Toxicol. 2011;108(3):208\u201313. https:\/\/doi.org\/10.1111\/j.1742-7843.2010.00657.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"1510_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","volume":"51","author":"MJ Brill","year":"2012","unstructured":"Brill MJ, Diepstraten J, van Rongen A, et al. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012;51(5):277\u2013304. https:\/\/doi.org\/10.2165\/11599410-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1510_CR39","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1007\/s00394-020-02421-y","volume":"60","author":"M Zarezadeh","year":"2021","unstructured":"Zarezadeh M, Saedisomeolia A, Shekarabi M, et al. The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies. Eur J Nutr. 2021;60(6):2905\u201321. https:\/\/doi.org\/10.1007\/s00394-020-02421-y.","journal-title":"Eur J Nutr"},{"issue":"Suppl 1","key":"1510_CR40","doi-asserted-by":"publisher","first-page":"i16","DOI":"10.1093\/bja\/aeq312","volume":"105","author":"J Ingrande","year":"2010","unstructured":"Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010;105(Suppl 1):i16-23. https:\/\/doi.org\/10.1093\/bja\/aeq312.","journal-title":"Br J Anaesth"},{"issue":"2","key":"1510_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.accpm.2019.12.009","volume":"39","author":"A De Jong","year":"2020","unstructured":"De Jong A, Roll\u00e9 A, Souche FR, et al. How can I manage anaesthesia in obese patients? Anaesth Crit Care Pain Med. 2020;39(2):229\u201338. https:\/\/doi.org\/10.1016\/j.accpm.2019.12.009.","journal-title":"Anaesth Crit Care Pain Med."},{"issue":"12","key":"1510_CR42","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.3390\/jcm11123543","volume":"11","author":"IW Lee","year":"2022","unstructured":"Lee IW, Schraag S. The Use of Intravenous Lidocaine in Perioperative Medicine: Anaesthetic, Analgesic and Immune-Modulatory Aspects. J Clin Med. 2022;11(12):3543. https:\/\/doi.org\/10.3390\/jcm11123543.","journal-title":"J Clin Med"},{"issue":"9","key":"1510_CR43","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/psp4.13189","volume":"13","author":"LF Pippa","year":"2024","unstructured":"Pippa LF, Vozmediano V, Mitrov-Winkelmolen L, Touw D, Soliman A, Cristofoletti R, et al. Impact of obesity and roux-en-Y gastric bypass on the pharmacokinetics of (R)- and (S)-omeprazole and intragastric pH. CPT Pharmacomet Syst Pharmacol. 2024;13(9):1528\u201341. https:\/\/doi.org\/10.1002\/psp4.13189.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"1","key":"1510_CR44","doi-asserted-by":"publisher","first-page":"20405","DOI":"10.1038\/s41598-019-57002-9","volume":"9","author":"J Rodr\u00edguez-Morat\u00f3","year":"2019","unstructured":"Rodr\u00edguez-Morat\u00f3 J, Goday A, Langohr K, Pujadas M, Civit E, P\u00e9rez-Ma\u00f1\u00e1 C, et al. Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity. Sci Rep. 2019;9(1):20405. https:\/\/doi.org\/10.1038\/s41598-019-57002-9.","journal-title":"Sci Rep"},{"issue":"1","key":"1510_CR45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.xphs.2020.10.027","volume":"110","author":"V Krogstad","year":"2021","unstructured":"Krogstad V, Peric A, Robertsen I, Kringen MK, Vistnes M, Hjelmes\u00e6th J, et al. Correlation of body weight and composition with hepatic activities of cytochrome P450 enzymes. J Pharm Sci. 2021;110(1):432\u20137. https:\/\/doi.org\/10.1016\/j.xphs.2020.10.027.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1510_CR46","first-page":"8","volume":"37","author":"M Kotlyar","year":"1999","unstructured":"Kotlyar M, Carson SW. Effects of obesity on the cytochrome P450 enzyme system. Int J Clin Pharmacol Ther. 1999;37(1):8\u201319.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"12","key":"1510_CR47","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s40265-018-0955-x","volume":"78","author":"M Beaussier","year":"2018","unstructured":"Beaussier M, Delbos A, Maurice-Szamburski A, Ecoffey C, Mercadal L. Perioperative use of intravenous lidocaine. Drugs. 2018;78(12):1229\u201346. https:\/\/doi.org\/10.1007\/s40265-018-0955-x.","journal-title":"Drugs"},{"key":"1510_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16531","author":"AR Tognolini","year":"2025","unstructured":"Tognolini AR, Liu X, Pandey S, Roberts JA, Wallis SC, Jackson D, Eley VA. Dosing optimisation of intravenous lidocaine in patients with class 1\u20133 obesity by population pharmacokinetic analysis. Anaesthesia. 2025. https:\/\/doi.org\/10.1111\/anae.16531. (Epub ahead of print).","journal-title":"Anaesthesia"},{"issue":"5","key":"1510_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40262-024-01373-4","volume":"63","author":"KW Foong","year":"2024","unstructured":"Foong KW, Chaw SH, Lo YL, Loh PS. Population pharmacokinetics of intravenous lidocaine in adults: a systematic review. Clin Pharmacokinet. 2024;63(5):623\u201343. https:\/\/doi.org\/10.1007\/s40262-024-01373-4.","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-025-01510-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:37:16Z","timestamp":1757180236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-025-01510-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1510"],"URL":"https:\/\/doi.org\/10.1007\/s40262-025-01510-7","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"13 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was funded by Sichuan Science and Technology Program to Zhenlei Wang with Grant number 2023YFS0047 and by National Natural Science Foundation of China to Zhenlei Wang with Grant number 81903722.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"This work was conducted in accordance with the Helsinki Declaration, approved by the Medical Ethics Committee of the Affiliated Hospital of North Sichuan Medical College, China (2022ER398-1) and registered at the Chinese Clinical Trial Registry (www.chictr.org.cn; ChiCTR2200064980).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all patients.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent for publication was obtained from all study participants, including their partners, caregivers, or legal representatives, prior to their participation in the research.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data that support the findings of this study are available from the corresponding author upon reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conceptualization and Writing: M-Y.Z; Methodology: YJ; Formal analysis and investigation: X-Y.Y, C-Q.H, and MH; Supervision: F-P.T and Z-L.W. All the authors reviewed and approved this manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}